Pfizer Oncology to Present on Safety Biomarkers, Regulatory Strategies, and Risk Management in Oncology IND Programs at GTCbio`s Rediscovering Biomarkers-Detection, Development and Validation Conference
Released on = June 21, 2007, 1:57 pm
Press Release Author = GTCbio
Industry = Pharmaceuticals
Press Release Summary = Dr. Howard Fingert, Senior Director, Signal Transduction
Development Program at Pfizer Oncology will present on Safety Biomarkers, Regulatory
Strategies, and Risk Management in Oncology IND Programs at GTCbio’s Rediscovering
Biomarkers: Detection, Development & Validation Conference taking place on July
23-24, 2007 at the San Diego Marriott La Jolla in La Jolla, CA.
Press Release Body = Dr. Howard Fingert, Senior Director, Signal Transduction
Development Program at Pfizer Oncology will present on Safety Biomarkers, Regulatory
Strategies, and Risk Management in Oncology IND Programs at GTCbio’s Rediscovering
Biomarkers: Detection, Development & Validation Conference taking place on July
23-24, 2007 at the San Diego Marriott La Jolla in La Jolla, CA.
For clinical and regulatory strategies in oncology development, safety biomarkers
are employed with broad applications. Laboratory results, used as safety biomarkers,
can influence decision making at many levels during development of cancer
treatments, including (1) protocol eligibility; (2) analyses to characterize the
safety profile; and (3) treatment delivery, based on rules to modify or discontinue
treatment. With the increasing applications of safety biomarkers in clinical
studies, consideration must be given to unintended consequences, including
limitations to dose delivery and determination of the recommended phase 2 dose. This
presentation will review recent clinical experiences with cardiac safety biomarkers
used to support development of oncology therapeutics.
GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference
provides comprehensive coverage of a wide range of topics including Biomarker
Application in Oncology Clinical Development, Drug Discovery, Development and
Diagnostics of Biomarkers, Tools for Improving Measurement, Safety and Validation of
Biomarkers, and Upcoming Technology and Trends.
For more information including a detailed agenda, exhibitor opportunities and
registration information visit
http://www.gtcbio.com/conference/conferenceDetails.aspx?id
Web Site = http://www.gtcbio.com
Contact Details = ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.
2012
